On 2025-3-14 Global Info Research released【Global Burn and Scald Medicine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031】. This report includes an overview of the development of the Burn and Scald Medicine industry chain, the market status of Consumer Electronics (Nickel-Zinc Ferrite Core, Mn-Zn Ferrite Core), Household Appliances (Nickel-Zinc Ferrite Core, Mn-Zn Ferrite Core), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Burn and Scald Medicine.
Sample Report Request Burn and Scald Medicine
https://www.globalinforesearch.com/reports/2479046/burn-and-scald-medicine
According to our (Global Info Research) latest study, the global Burn and Scald Medicine market size was valued at US$ 4649 million in 2024 and is forecast to a readjusted size of USD 6498 million by 2031 with a CAGR of 4.9% during review period.
Market segment by Type：Dressing、Ointment、Spray
Market segment by Application：Hospital、Clinic、Pharmacy、Online
Major players covered： Nipro、MediWound、STADA Arzneimittel、Elastoplast、Pfizer、Bharat Biotech、Paul Hartmann、Ono Pharmaceutical、Centaur Pharmaceuticals、Kedrion Biopharma、Smith & Nephew、ConvaTec、B. Braun Melsungen、Coloplast、Mölnlycke Health Care、Medline Industries、Hartmann、Ferndale Pharmaceuticals、Guizhou Jingcheng Medicine、Mebo Pharmaceutical Technology、Shanghai Tenry Pharm、Guilin Huanuo Gene Pharmaceutical、Shanghai Haohai Biotechnology、Beijing SL Pharmaceutical、Hubei Mayinglong Pharmaceutical、Jianmin Group、Tianjin Pharm Group、Cardinal Health、Integra LifeSciences、Deroyal、DermaRite Industries
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Burn and Scald Medicine by Type
1.3.1 Overview: Global Burn and Scald Medicine Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Burn and Scald Medicine Consumption Value Market Share by Type in 2024
1.3.3 Dressing
1.3.4 Ointment
1.3.5 Spray
1.4 Global Burn and Scald Medicine Market by Application
1.4.1 Overview: Global Burn and Scald Medicine Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Pharmacy
1.4.5 Online
1.5 Global Burn and Scald Medicine Market Size & Forecast
1.6 Global Burn and Scald Medicine Market Size and Forecast by Region
1.6.1 Global Burn and Scald Medicine Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Burn and Scald Medicine Market Size by Region, (2020-2031)
1.6.3 North America Burn and Scald Medicine Market Size and Prospect (2020-2031)
1.6.4 Europe Burn and Scald Medicine Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Burn and Scald Medicine Market Size and Prospect (2020-2031)
1.6.6 South America Burn and Scald Medicine Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Burn and Scald Medicine Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 Nipro
2.1.1 Nipro Details
2.1.2 Nipro Major Business
2.1.3 Nipro Burn and Scald Medicine Product and Solutions
2.1.4 Nipro Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Nipro Recent Developments and Future Plans
2.2 MediWound
2.2.1 MediWound Details
2.2.2 MediWound Major Business
2.2.3 MediWound Burn and Scald Medicine Product and Solutions
2.2.4 MediWound Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 MediWound Recent Developments and Future Plans
2.3 STADA Arzneimittel
2.3.1 STADA Arzneimittel Details
2.3.2 STADA Arzneimittel Major Business
2.3.3 STADA Arzneimittel Burn and Scald Medicine Product and Solutions
2.3.4 STADA Arzneimittel Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 STADA Arzneimittel Recent Developments and Future Plans
2.4 Elastoplast
2.4.1 Elastoplast Details
2.4.2 Elastoplast Major Business
2.4.3 Elastoplast Burn and Scald Medicine Product and Solutions
2.4.4 Elastoplast Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Elastoplast Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Burn and Scald Medicine Product and Solutions
2.5.4 Pfizer Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Bharat Biotech
2.6.1 Bharat Biotech Details
2.6.2 Bharat Biotech Major Business
2.6.3 Bharat Biotech Burn and Scald Medicine Product and Solutions
2.6.4 Bharat Biotech Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Bharat Biotech Recent Developments and Future Plans
2.7 Paul Hartmann
2.7.1 Paul Hartmann Details
2.7.2 Paul Hartmann Major Business
2.7.3 Paul Hartmann Burn and Scald Medicine Product and Solutions
2.7.4 Paul Hartmann Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Paul Hartmann Recent Developments and Future Plans
2.8 Ono Pharmaceutical
2.8.1 Ono Pharmaceutical Details
2.8.2 Ono Pharmaceutical Major Business
2.8.3 Ono Pharmaceutical Burn and Scald Medicine Product and Solutions
2.8.4 Ono Pharmaceutical Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Ono Pharmaceutical Recent Developments and Future Plans
2.9 Centaur Pharmaceuticals
2.9.1 Centaur Pharmaceuticals Details
2.9.2 Centaur Pharmaceuticals Major Business
2.9.3 Centaur Pharmaceuticals Burn and Scald Medicine Product and Solutions
2.9.4 Centaur Pharmaceuticals Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Centaur Pharmaceuticals Recent Developments and Future Plans
2.10 Kedrion Biopharma
2.10.1 Kedrion Biopharma Details
2.10.2 Kedrion Biopharma Major Business
2.10.3 Kedrion Biopharma Burn and Scald Medicine Product and Solutions
2.10.4 Kedrion Biopharma Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Kedrion Biopharma Recent Developments and Future Plans
2.11 Smith & Nephew
2.11.1 Smith & Nephew Details
2.11.2 Smith & Nephew Major Business
2.11.3 Smith & Nephew Burn and Scald Medicine Product and Solutions
2.11.4 Smith & Nephew Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Smith & Nephew Recent Developments and Future Plans
2.12 ConvaTec
2.12.1 ConvaTec Details
2.12.2 ConvaTec Major Business
2.12.3 ConvaTec Burn and Scald Medicine Product and Solutions
2.12.4 ConvaTec Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 ConvaTec Recent Developments and Future Plans
2.13 B. Braun Melsungen
2.13.1 B. Braun Melsungen Details
2.13.2 B. Braun Melsungen Major Business
2.13.3 B. Braun Melsungen Burn and Scald Medicine Product and Solutions
2.13.4 B. Braun Melsungen Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 B. Braun Melsungen Recent Developments and Future Plans
2.14 Coloplast
2.14.1 Coloplast Details
2.14.2 Coloplast Major Business
2.14.3 Coloplast Burn and Scald Medicine Product and Solutions
2.14.4 Coloplast Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Coloplast Recent Developments and Future Plans
2.15 Mölnlycke Health Care
2.15.1 Mölnlycke Health Care Details
2.15.2 Mölnlycke Health Care Major Business
2.15.3 Mölnlycke Health Care Burn and Scald Medicine Product and Solutions
2.15.4 Mölnlycke Health Care Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Mölnlycke Health Care Recent Developments and Future Plans
2.16 Medline Industries
2.16.1 Medline Industries Details
2.16.2 Medline Industries Major Business
2.16.3 Medline Industries Burn and Scald Medicine Product and Solutions
2.16.4 Medline Industries Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Medline Industries Recent Developments and Future Plans
2.17 Hartmann
2.17.1 Hartmann Details
2.17.2 Hartmann Major Business
2.17.3 Hartmann Burn and Scald Medicine Product and Solutions
2.17.4 Hartmann Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Hartmann Recent Developments and Future Plans
2.18 Ferndale Pharmaceuticals
2.18.1 Ferndale Pharmaceuticals Details
2.18.2 Ferndale Pharmaceuticals Major Business
2.18.3 Ferndale Pharmaceuticals Burn and Scald Medicine Product and Solutions
2.18.4 Ferndale Pharmaceuticals Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Ferndale Pharmaceuticals Recent Developments and Future Plans
2.19 Guizhou Jingcheng Medicine
2.19.1 Guizhou Jingcheng Medicine Details
2.19.2 Guizhou Jingcheng Medicine Major Business
2.19.3 Guizhou Jingcheng Medicine Burn and Scald Medicine Product and Solutions
2.19.4 Guizhou Jingcheng Medicine Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Guizhou Jingcheng Medicine Recent Developments and Future Plans
2.20 Mebo Pharmaceutical Technology
2.20.1 Mebo Pharmaceutical Technology Details
2.20.2 Mebo Pharmaceutical Technology Major Business
2.20.3 Mebo Pharmaceutical Technology Burn and Scald Medicine Product and Solutions
2.20.4 Mebo Pharmaceutical Technology Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 Mebo Pharmaceutical Technology Recent Developments and Future Plans
2.21 Shanghai Tenry Pharm
2.21.1 Shanghai Tenry Pharm Details
2.21.2 Shanghai Tenry Pharm Major Business
2.21.3 Shanghai Tenry Pharm Burn and Scald Medicine Product and Solutions
2.21.4 Shanghai Tenry Pharm Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 Shanghai Tenry Pharm Recent Developments and Future Plans
2.22 Guilin Huanuo Gene Pharmaceutical
2.22.1 Guilin Huanuo Gene Pharmaceutical Details
2.22.2 Guilin Huanuo Gene Pharmaceutical Major Business
2.22.3 Guilin Huanuo Gene Pharmaceutical Burn and Scald Medicine Product and Solutions
2.22.4 Guilin Huanuo Gene Pharmaceutical Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 Guilin Huanuo Gene Pharmaceutical Recent Developments and Future Plans
2.23 Shanghai Haohai Biotechnology
2.23.1 Shanghai Haohai Biotechnology Details
2.23.2 Shanghai Haohai Biotechnology Major Business
2.23.3 Shanghai Haohai Biotechnology Burn and Scald Medicine Product and Solutions
2.23.4 Shanghai Haohai Biotechnology Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.23.5 Shanghai Haohai Biotechnology Recent Developments and Future Plans
2.24 Beijing SL Pharmaceutical
2.24.1 Beijing SL Pharmaceutical Details
2.24.2 Beijing SL Pharmaceutical Major Business
2.24.3 Beijing SL Pharmaceutical Burn and Scald Medicine Product and Solutions
2.24.4 Beijing SL Pharmaceutical Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.24.5 Beijing SL Pharmaceutical Recent Developments and Future Plans
2.25 Hubei Mayinglong Pharmaceutical
2.25.1 Hubei Mayinglong Pharmaceutical Details
2.25.2 Hubei Mayinglong Pharmaceutical Major Business
2.25.3 Hubei Mayinglong Pharmaceutical Burn and Scald Medicine Product and Solutions
2.25.4 Hubei Mayinglong Pharmaceutical Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.25.5 Hubei Mayinglong Pharmaceutical Recent Developments and Future Plans
2.26 Jianmin Group
2.26.1 Jianmin Group Details
2.26.2 Jianmin Group Major Business
2.26.3 Jianmin Group Burn and Scald Medicine Product and Solutions
2.26.4 Jianmin Group Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.26.5 Jianmin Group Recent Developments and Future Plans
2.27 Tianjin Pharm Group
2.27.1 Tianjin Pharm Group Details
2.27.2 Tianjin Pharm Group Major Business
2.27.3 Tianjin Pharm Group Burn and Scald Medicine Product and Solutions
2.27.4 Tianjin Pharm Group Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.27.5 Tianjin Pharm Group Recent Developments and Future Plans
2.28 Cardinal Health
2.28.1 Cardinal Health Details
2.28.2 Cardinal Health Major Business
2.28.3 Cardinal Health Burn and Scald Medicine Product and Solutions
2.28.4 Cardinal Health Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.28.5 Cardinal Health Recent Developments and Future Plans
2.29 Integra LifeSciences
2.29.1 Integra LifeSciences Details
2.29.2 Integra LifeSciences Major Business
2.29.3 Integra LifeSciences Burn and Scald Medicine Product and Solutions
2.29.4 Integra LifeSciences Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.29.5 Integra LifeSciences Recent Developments and Future Plans
2.30 Deroyal
2.30.1 Deroyal Details
2.30.2 Deroyal Major Business
2.30.3 Deroyal Burn and Scald Medicine Product and Solutions
2.30.4 Deroyal Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.30.5 Deroyal Recent Developments and Future Plans
2.31 DermaRite Industries
2.31.1 DermaRite Industries Details
2.31.2 DermaRite Industries Major Business
2.31.3 DermaRite Industries Burn and Scald Medicine Product and Solutions
2.31.4 DermaRite Industries Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
2.31.5 DermaRite Industries Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Burn and Scald Medicine Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Burn and Scald Medicine by Company Revenue
3.2.2 Top 3 Burn and Scald Medicine Players Market Share in 2024
3.2.3 Top 6 Burn and Scald Medicine Players Market Share in 2024
3.3 Burn and Scald Medicine Market: Overall Company Footprint Analysis
3.3.1 Burn and Scald Medicine Market: Region Footprint
3.3.2 Burn and Scald Medicine Market: Company Product Type Footprint
3.3.3 Burn and Scald Medicine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Burn and Scald Medicine Consumption Value and Market Share by Type (2020-2025)
4.2 Global Burn and Scald Medicine Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Burn and Scald Medicine Consumption Value Market Share by Application (2020-2025)
5.2 Global Burn and Scald Medicine Market Forecast by Application (2026-2031)
6 North America
6.1 North America Burn and Scald Medicine Consumption Value by Type (2020-2031)
6.2 North America Burn and Scald Medicine Market Size by Application (2020-2031)
6.3 North America Burn and Scald Medicine Market Size by Country
6.3.1 North America Burn and Scald Medicine Consumption Value by Country (2020-2031)
6.3.2 United States Burn and Scald Medicine Market Size and Forecast (2020-2031)
6.3.3 Canada Burn and Scald Medicine Market Size and Forecast (2020-2031)
6.3.4 Mexico Burn and Scald Medicine Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Burn and Scald Medicine Consumption Value by Type (2020-2031)
7.2 Europe Burn and Scald Medicine Consumption Value by Application (2020-2031)
7.3 Europe Burn and Scald Medicine Market Size by Country
7.3.1 Europe Burn and Scald Medicine Consumption Value by Country (2020-2031)
7.3.2 Germany Burn and Scald Medicine Market Size and Forecast (2020-2031)
7.3.3 France Burn and Scald Medicine Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Burn and Scald Medicine Market Size and Forecast (2020-2031)
7.3.5 Russia Burn and Scald Medicine Market Size and Forecast (2020-2031)
7.3.6 Italy Burn and Scald Medicine Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Burn and Scald Medicine Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Burn and Scald Medicine Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Burn and Scald Medicine Market Size by Region
8.3.1 Asia-Pacific Burn and Scald Medicine Consumption Value by Region (2020-2031)
8.3.2 China Burn and Scald Medicine Market Size and Forecast (2020-2031)
8.3.3 Japan Burn and Scald Medicine Market Size and Forecast (2020-2031)
8.3.4 South Korea Burn and Scald Medicine Market Size and Forecast (2020-2031)
8.3.5 India Burn and Scald Medicine Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Burn and Scald Medicine Market Size and Forecast (2020-2031)
8.3.7 Australia Burn and Scald Medicine Market Size and Forecast (2020-2031)
9 South America
9.1 South America Burn and Scald Medicine Consumption Value by Type (2020-2031)
9.2 South America Burn and Scald Medicine Consumption Value by Application (2020-2031)
9.3 South America Burn and Scald Medicine Market Size by Country
9.3.1 South America Burn and Scald Medicine Consumption Value by Country (2020-2031)
9.3.2 Brazil Burn and Scald Medicine Market Size and Forecast (2020-2031)
9.3.3 Argentina Burn and Scald Medicine Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Burn and Scald Medicine Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Burn and Scald Medicine Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Burn and Scald Medicine Market Size by Country
10.3.1 Middle East & Africa Burn and Scald Medicine Consumption Value by Country (2020-2031)
10.3.2 Turkey Burn and Scald Medicine Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Burn and Scald Medicine Market Size and Forecast (2020-2031)
10.3.4 UAE Burn and Scald Medicine Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Burn and Scald Medicine Market Drivers
11.2 Burn and Scald Medicine Market Restraints
11.3 Burn and Scald Medicine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Burn and Scald Medicine Industry Chain
12.2 Burn and Scald Medicine Upstream Analysis
12.3 Burn and Scald Medicine Midstream Analysis
12.4 Burn and Scald Medicine Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
About Us:
GlobaI Info Research
Web: https://www.globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
US: 001-347 966 1888
Email: report@globalinforesearch.com
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
No comments:
Post a Comment